![Maria Palasis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Maria Palasis
Vorstandsvorsitzender bei
LYRA THERAPEUTICS, INC.
Vermögen: 1 Mio $ am 31.05.2026
Profil
Maria Palasis is Chief Executive Officer & Director at Lyra Therapeutics, Inc. since 2026.
Dr. Palasis is Director at PanTher Therapeutics, Inc. Dr. Palasis is Director at Medexecwomen.
Dr. Palasis is Independent Director at Beta Bionics, Inc. since 2025.
Formerly, Dr. Palasis was President, Chief Executive Officer & Director at Arsenal Medical, Inc. from 2015 to 2018.
Dr. Palasis was Director at Boston Scientific Corp.
from 1995 to 2008.
Dr. Palasis was Director at Beta Bionics, Inc. from 2022 to 2023.
Education includes undergraduate and doctorate degrees from the University of Cincinnati (Ohio).
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
LYRA THERAPEUTICS, INC. 61.68% | 01.04.2026 | 1’094’733 ( 61.68% ) | 810 102 $ | 31.05.2026 |
BETA BIONICS, INC. 0.07% | 21.05.2026 | 29’397 ( 0.07% ) | 356 292 $ | 31.05.2026 |
BETA BIONICS, INC. -.--% | 29.01.2025 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Maria Palasis
| Unternehmen | Position | Beginn |
|---|---|---|
| LYRA THERAPEUTICS, INC. | Vorstandsvorsitzender | 01.01.2015 |
| BETA BIONICS, INC. | Direktor/Vorstandsmitglied | 01.01.2025 |
PanTher Therapeutics, Inc.
 PanTher Therapeutics, Inc. Medical/Nursing ServicesHealth Services Provides health care services | Direktor/Vorstandsmitglied | - |
Medexecwomen | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Maria Palasis
| Unternehmen | Position | Ende |
|---|---|---|
| BETA BIONICS, INC. | Direktor/Vorstandsmitglied | 01.09.2023 |
Arsenal Medical, Inc.
 Arsenal Medical, Inc. Medical SpecialtiesHealth Technology Develops biomaterials provides local therapy for important medical conditions across therapeutic areas | Vorstandsvorsitzender | 01.06.2018 |
| BOSTON SCIENTIFIC CORPORATION | Direktor/Vorstandsmitglied | 01.01.2008 |
Ausbildung von Maria Palasis
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
85
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Boston Scientific Corp.
 Boston Scientific Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets cardiology, endoscopy, peripheral intervention, urology & neuromodulation equipment | Health Technology |
Arsenal Medical, Inc.
Arsenal Medical, Inc. Medical SpecialtiesHealth Technology Develops biomaterials provides local therapy for important medical conditions across therapeutic areas | Health Technology |
University of Cincinnati (Ohio)
 University of Cincinnati (Ohio) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lyra Therapeutics, Inc.
 Lyra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage therapeutics company which develops and commercializes novel integrated drugs for treatment of patients with ear, nose and throat and ENT diseases | Health Technology |
PanTher Therapeutics, Inc.
PanTher Therapeutics, Inc. Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
Beta Bionics, Inc.
 Beta Bionics, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets medical devices for diabetes disease | Health Technology |
Medexecwomen | Commercial Services |
